Experience

Pulmonx Corporation

• United States
• Medical Equipment Manufacturing
• 100 - 200 Employee

• Vice President

  • Feb 2020 - Present

• Director Of Marketing And Product Management

  • May 2018 - Feb 2020


Clinical and Marketing Consultant
• IT Services and IT Consulting
• Principal

  • Jan 2017 - Present


Factory CRO for Medical Devices and IVDs

• Netherlands
• Medical Equipment Manufacturing

• General Manager, US

  • Jun 2017 - May 2018

  San Francisco Bay Area Factory CRO is a full service Contract Research Organization and global leader of specialization in medical device trials. Our focus lies in the complete management of clinical studies for medical devices, IVDs, biologicals, and drug-device combinations. From determining where and how to start your clinical trial, to identifying the most influential KOLs across Europe, our expertise will help you run the most efficient and cost-effective study possible. In addition to medical devices we have… Show more Factory CRO is a full service Contract Research Organization and global leader of specialization in medical device trials. Our focus lies in the complete management of clinical studies for medical devices, IVDs, biologicals, and drug-device combinations. From determining where and how to start your clinical trial, to identifying the most influential KOLs across Europe, our expertise will help you run the most efficient and cost-effective study possible. In addition to medical devices we have extensive experience in IVD studies, biological studies and device-drug combination, as well as therapeutic and surgical expertise, gained over the course of 20 years. On the application of the medical device, we are able to go into the field to provide in-person technical training for investigators. Show less



Carbylan Therapeutics

• United States
• 1 - 100 Employee

• V.P., Marketing and Clinical Affairs

  • Jun 2008 - Dec 2016

  Palo Alto, CA Carbylan Therapeutics is a publically traded company developing a next generation, single injection therapy for treating join pain caused by Osteoarthritis. Carbylan is currently conducting Phase 3 clinical trials for its lead product Hydros-TA. Hydros-TA is a combination therapy, which combines a low dose steroid and a long last hyaluronic acid, designed to provide rapid and sustained pain relief.



Carbylan BioSurgery

• Vice President, Marketing

  • Feb 2006 - Jun 2008

  Palo Alto Carbylan BioSurgery was a privately held company developing a next generation, single injection therapy for treating join pain caused by Osteoarthritis.



Baxter Healthcare

• Australia
• 1 - 100 Employee

• Group Manager

  • 2002 - 2006

  Westlake Village, California Baxter’s BioScience business is a leader in recombinant and plasma-based protein replacement therapies to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products and developmental technology used in adult stem-cell therapies; and vaccines.



Cohesion Technologies

• United States
• Computers and Electronics Manufacturing

• Director, Marketing

  • 1998 - 2004

  Cohesion Technologies was a publically traded biomaterials company that developed and marketed biosurgical hemostats, sealants, and adhesives. Cohesion was acquired by Angiotech Pharmaceuticals in 2002.



Collagen Corporation

• Biotechnology Research

• Research Scientist

  • 1992 - 1996

  Palo Alto, CA Collagen Corporation was a publically traded, pioneering company in the aesthetics space. Collagen developed biomaterials for soft tissue augmentation and breast implants. Collagen Corporation which later changed its name to Collagen Aesthetics was acquired by Inamed Corporation in 1999.